{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04685616",
            "orgStudyIdInfo": {
                "id": "RADAR"
            },
            "secondaryIdInfos": [
                {
                    "id": "2020-005160-65",
                    "type": "EUDRACT_NUMBER"
                },
                {
                    "id": "IISR X25041",
                    "type": "OTHER_GRANT",
                    "domain": "Takeda Pharmaceutical Company Ltd"
                },
                {
                    "id": "UCL/15/0105",
                    "type": "OTHER",
                    "domain": "UCL"
                },
                {
                    "id": "CCTG HD.12",
                    "type": "OTHER",
                    "domain": "CCTG"
                },
                {
                    "id": "IRB number 20230081",
                    "type": "OTHER",
                    "domain": "University of Miami"
                }
            ],
            "organization": {
                "fullName": "University College, London",
                "class": "OTHER"
            },
            "briefTitle": "Brentuximab Vedotin in Early Stage Hodgkin Lymphoma",
            "officialTitle": "A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma",
            "acronym": "RADAR",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "brentuximab-vedotin-in-early-stage-hodgkin-lymphoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-04-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2030-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2032-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-11-27",
            "studyFirstSubmitQcDate": "2020-12-21",
            "studyFirstPostDateStruct": {
                "date": "2020-12-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University College, London",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Takeda",
                    "class": "INDUSTRY"
                },
                {
                    "name": "University of Miami",
                    "class": "OTHER"
                },
                {
                    "name": "European Organisation for Research and Treatment of Cancer - EORTC",
                    "class": "NETWORK"
                },
                {
                    "name": "Australasian Leukaemia and Lymphoma Group",
                    "class": "OTHER"
                },
                {
                    "name": "Seagen Inc.",
                    "class": "INDUSTRY"
                },
                {
                    "name": "Canadian Cancer Trials Group",
                    "class": "NETWORK"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led and sponsored by University College London (UCL) and conducted in Europe and Australia/New Zealand. Trial 2 will be led by the Canadian Cancer Trials Group (CCTG) and conducted in North America, with CCTG the regulatory sponsor in Canada, and University of Miami the regulatory sponsor and IND holder in the US. Datasets from Trial 1 and Trial 2 will be combined to achieve the total sample size. Data analysis will be performed by UCL and therefore UCL is responsible for the clinicaltrials.gov entry.\n\nEligible patients will be randomised to receive either ABVD or A2VD chemotherapy.\n\nAn interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt subsequent treatment. Patients will receive a total of 3-4 cycles of chemotherapy and may also receive involved site radiotherapy as consolidation.\n\nPatients will be followed up for a minimum of 5 years after treatment.",
            "detailedDescription": "Eligible patients will be randomised to receive either ABVD chemotherapy (doxorubicin, bleomycin, vinblastine and dacarbazine) or A2VD chemotherapy (doxorubicin, brentuximab vedotin, vinblastine and dacarbazine, with growth factor support).\n\nIf patients agree, they will have a PET-CT scan after 1 cycle (PET1). The result of this scan will be blinded and used for exploratory endpoints only. Treatment will not be influenced by the result of this scan.\n\nAll patients will have a PET-CT scan after 2 cycles of treatment (PET2) which will be centrally reviewed. The Deauville score from central review will be used to risk adapt subsequent therapy as follows:\n\n* Patients with Deauville score 1-3 will have one further cycle of their randomised chemotherapy and then enter follow up.\n* Patients with Deauville score 4 will have two further cycles of their randomised chemotherapy followed by involved site radiotherapy\n* Patients with Deauville score 5 will be withdrawn from trial treatment. They will have further treatment at their treating clinician's discretion and will enter follow up for the trial.\n\nPatients with Deauville score 4 on PET2 will have a final PET-CT scan to confirm adequate treatment response.\n\nPatients will be followed up for a minimum of 5 years after completing treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Hodgkin Lymphoma"
            ],
            "keywords": [
                "PET-response adapted",
                "Stage IA/IIA Hodgkin lymphoma",
                "Brentuximab vedotin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 1042,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ABVD +/- ISRT",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "2 x 28 day cycles of ABVD: Doxorubicin 25mg/m\\^2 IV days 1 \\& 15 Bleomycin 10000 IU/m\\^2 days 1 \\& 15 Vinblastine 6mg/m\\^2 days 1 \\& 15 Dacarbazine 375mg/m\\^2 days 1 \\& 15\n\nPET-CT after 2 cycles will determine subsequent treatment:\n\nDeauville score 1-3 (PET CMR): 1 further cycle of ABVD then follow up Deauville score 4 (PET positive): 2 further cycles of ABVD followed by involved site radiotherapy (ISRT) Deauville score 5: withdraw from trial treatment; further treatment will be given at the treating clinician's discretion. Enter follow up for the trial.",
                    "interventionNames": [
                        "Radiation: Involved site radiotherapy",
                        "Drug: Doxorubicin",
                        "Drug: Bleomycin",
                        "Drug: Vinblastine",
                        "Drug: Dacarbazine"
                    ]
                },
                {
                    "label": "A2VD +/- ISRT",
                    "type": "EXPERIMENTAL",
                    "description": "2 x 28 day cycles of A2VD: Doxorubicin 25mg/m\\^2 IV days 1 \\& 15 Brentuximab vedotin 1.2mg/kg (max 120mg) days 1 \\& 15 Vinblastine 6mg/m\\^2 days 1 \\& 15 Dacarbazine 375mg/m\\^2 days 1 \\& 15 Filgrastim (or equivalent haematopoietic growth factor) for 5-7 days from day 2 and day 16 (or single dose of peg-filgrastim on days 2 \\& 16)\n\nPET-CT after 2 cycles will determine subsequent treatment:\n\nDeauville score 1-3 (PET CMR): 1 further cycle of A2VD then follow up Deauville score 4 (PET positive): 2 further cycles of A2VD followed by involved site radiotherapy (ISRT) Deauville score 5: withdraw from trial treatment; further treatment will be given at the treating clinician's discretion. Enter follow up for the trial.",
                    "interventionNames": [
                        "Radiation: Involved site radiotherapy",
                        "Drug: Doxorubicin",
                        "Drug: Brentuximab vedotin",
                        "Drug: Vinblastine",
                        "Drug: Dacarbazine",
                        "Drug: Haematopoietic growth factor"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "Involved site radiotherapy",
                    "description": "Involved site radiotherapy as per International Lymphoma Radiation Oncology Group (ILROG) guidelines.\n\nRecommended dose 30Gy",
                    "armGroupLabels": [
                        "A2VD +/- ISRT",
                        "ABVD +/- ISRT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Doxorubicin",
                    "description": "See arm description",
                    "armGroupLabels": [
                        "A2VD +/- ISRT",
                        "ABVD +/- ISRT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bleomycin",
                    "description": "See arm description",
                    "armGroupLabels": [
                        "ABVD +/- ISRT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Brentuximab vedotin",
                    "description": "See arm description",
                    "armGroupLabels": [
                        "A2VD +/- ISRT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Vinblastine",
                    "description": "See arm description",
                    "armGroupLabels": [
                        "A2VD +/- ISRT",
                        "ABVD +/- ISRT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dacarbazine",
                    "description": "See arm description",
                    "armGroupLabels": [
                        "A2VD +/- ISRT",
                        "ABVD +/- ISRT"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Haematopoietic growth factor",
                    "description": "See arm description",
                    "armGroupLabels": [
                        "A2VD +/- ISRT"
                    ],
                    "otherNames": [
                        "Filgrastim",
                        "G-CSF",
                        "Pegfilgrastim"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Progression free survival (PFS)",
                    "description": "Time from randomisation to first date of progression or death",
                    "timeFrame": "3 years from end of treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "PET-CMR (complete metabolic response) rate",
                    "description": "Proportion of patients who have Deauville score 1-3 on PET-CT scan",
                    "timeFrame": "At the end of cycle 2 (each cycle is 28 days)"
                },
                {
                    "measure": "Event-free survival (EFS)",
                    "description": "Time from randomisation to first date of progression, death or a positive PET2 scan (whichever occurs first)",
                    "timeFrame": "5 years from end of treatment"
                },
                {
                    "measure": "Overall survival (OS)",
                    "description": "Time from randomisation to death",
                    "timeFrame": "5 years from end of treatment"
                },
                {
                    "measure": "Incidence of second cancers and cardiovascular disease",
                    "description": "Proportion in each arm who develop a second cancer or cardiovascular disease",
                    "timeFrame": "5 years from end of treatment"
                },
                {
                    "measure": "Safety and toxicity of ABVD and A2VD as described by CTCAE v5.0",
                    "description": "Numbers of patients experiencing a grade 3+ adverse event of each type will be presented and compared between the arms. Only patients who start treatment will be included",
                    "timeFrame": "From start of treatment to 30 days post treatment"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Prognostic power of PET after 1 and 2 cycles of ABVD/A2VD",
                    "description": "7A Associations between PET1 Deauville score (DS) and PET2 DS; 7B Associations between PET1 DS and EFS; 7C Associations between PET1 DS and OS; 7D Associations between PET1 DS and PFS; 7E Associations between PET2 DS and EFS; 7F Associations between PET2 DS and OS; 7G Associations between PET2 DS and PFS; 7H Associations between EORTC baseline stratification and PET1 DS; 7I Associations between EORTC baseline stratification and PET2 DS; 7J Associations between EORTC baseline stratification and EFS; 7K Associations between EORTC baseline stratification and OS; 7L Associations between EORTC baseline stratification and EFS; 7M Associations between GHSG baseline stratification and PET1 DS; 7N Associations between GHSG baseline stratification and PET2 DS; 7O Associations between GHSG baseline stratification and EFS; 7P Associations between GHSG baseline stratification and OS; 7Q Associations between GHSG baseline stratification and EFS",
                    "timeFrame": "Up to 5 years after end of treatment"
                },
                {
                    "measure": "Prognostic and predictive power of baseline PET features",
                    "description": "The association of baseline quantitative PET parameters such as total lesion glycolysis (TLG) and PFS/EFS/OS will be assessed. The ability to predict PET score (PET1 and PET2) and Hodgkin lymphoma events within 3 years will be compared: 8A Associations between baseline quantitative PET parameters such as total lesion glycolysis (TLG) and PFS; 8B Associations between baseline quantitative PET parameters such as total lesion glycolysis (TLG) and OS; 8C Associations between baseline quantitative PET parameters such as total lesion glycolysis (TLG) and EFS; 8D Associations between baseline quantitative PET parameters such as total lesion glycolysis (TLG) and PET1 DS; 8E Associations between baseline quantitative PET parameters such as total lesion glycolysis (TLG) and PET2 DS",
                    "timeFrame": "Up to 3 years after end of treatment"
                },
                {
                    "measure": "Change in pulmonary function tests at end of treatment, 1 and 2 years",
                    "description": "Change from baseline pulmonary function test (DLCO/TLCO percentage of normal) will be compared",
                    "timeFrame": "3 months & 1 year after end of treatment"
                },
                {
                    "measure": "Correlation between maximum tumour dimension at baseline and end of treatment with PFS",
                    "description": "The relationship between maximum tumour dimension at baseline and at end of treatment and PFS will be examined. This may also be analysed within the groups that achieve/do not achieve CMR after 2 cycles and may also be adjusted for the use of consolidation radiotherapy",
                    "timeFrame": "Up to 5 years after end of treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Males and females aged 16-69 years (inclusive) (age range is 18-69 in US and EU)\n* Histologically confirmed classical Hodgkin lymphoma\n* Stage I or II supradiaphragmatic disease with no mediastinal bulk disease (defined as greater than a third of the transthoracic diameter at any level of thoracic vertebra as determined by CT) or B symptoms. Bulky disease at other sites is acceptable. Extranodal disease (single extranodal site (stage I) or contiguous nodal extension (stage II)) is acceptable.\n* ECOG performance status 0-2.\n* No previous treatment for Hodgkin lymphoma\n* Fit to receive anthracycline-based chemotherapy (patients with a history of ischaemic heart disease or hypertension should have a left ventricular ejection fraction of \u226550%)\n* Creatinine clearance (measured or calculated \\>40ml/min\n* Total bilirubin \\<1.5 x upper limit of normal, unless attributable to disease or known Gilbert's syndrome\n* ALT or AST \\< 2 x upper limit of normal\n* Adequate bone marrow function with neutrophils \u22651.0x10\\^9/l and platelets \u2265100x10\\^9/l\n* Haemoglobin \u22658g/dL\n* Willing and able to comply with the requirements of the protocol, including contraceptive advice, where applicable\n* Written informed consent\n\nExclusion Criteria:\n\n* Previous treatment for Hodgkin lymphoma, excluding short courses of oral corticosteroids at a dose of 100mg prednisolone (or equivalent) for up to 7 days\n* Infradiaphragmatic disease\n* Nodular lymphocyte predominant Hodgkin lymphoma\n* Absence of FDG-avid lesions on baseline PET scan\n* Age 70 years or over or age 15 years or under\n* Other cancer diagnosed with the last 5 years. Patients with completely excised carcinoma in situ of any type and basal or squamous cell carcinoma of the skin are not excluded\n* Recurrent or persistent other cancer within last 5 years irrespective of date of initial diagnosis\n* Pre-existing grade \u22651 sensory or motor neuropathy from any cause\n* History of or current progressive multi-focal leukoencephalopathy or other chronic condition of the brain\n* Symptomatic neurologic disease compromising normal activities of daily living or requiring medications\n* Infection with HIV, hepatitis C or active hepatitis B infection (surface antigen or DNA positive)\n* Any active systemic viral, bacterial or fungal infection requiring systemic antibiotics, antivirals or antifungals within 2 weeks prior to first trial drug dose\n* Receiving or recently treated with any other investigational agent (within 4 weeks of trial entry)\n* Pregnant or breastfeeding women\n* Known hypersensitivity to recombinant proteins, murine proteins, or to any excipient contained in the drug formulation of brentuximab vedotin or any component of ABVD\n* Known history of any cardiovascular or respiratory conditions that would preclude anthracycline or bleomycin administration\n* Other significant medical or psychiatric comorbidity that in the opinion of the investigator would make administration of ABVD or A2VD hazardous",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "16 Years",
            "maximumAge": "69 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "RADAR Trial Coordinator",
                    "role": "CONTACT",
                    "phone": "+44(0)207 679 9860",
                    "email": "ctc.radar@ucl.ac.uk"
                }
            ],
            "overallOfficials": [
                {
                    "name": "John Radford",
                    "affiliation": "University of Manchester / Christie Hospital, Manchester",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University - (Stanford Cancer Institute)",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Austin Yeung",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Ranjana Advani",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "University of Miami School of Medicine",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Safia Sawleh",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Craig Moskowitz",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Royal North Shore Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Leonards",
                    "state": "New South Wales",
                    "zip": "2065",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Keith Fay",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Keith Fay",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.82344,
                        "lon": 151.19836
                    }
                },
                {
                    "facility": "Townsville University Hospital",
                    "status": "RECRUITING",
                    "city": "Townsville",
                    "state": "Queensland",
                    "zip": "QLD 4814",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Jane Royle",
                            "role": "CONTACT",
                            "email": "Jane.Royle@health.qld.gov.au"
                        },
                        {
                            "name": "Jane Royle",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -19.26639,
                        "lon": 146.80569
                    }
                },
                {
                    "facility": "Royal Adelaide Hospital",
                    "status": "RECRUITING",
                    "city": "Adelaide",
                    "zip": "5000",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Pratyush Giri",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Pratyush Giri",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.92866,
                        "lon": 138.59863
                    }
                },
                {
                    "facility": "Box Hill Hospital",
                    "status": "RECRUITING",
                    "city": "Box Hill",
                    "zip": "VIC 3128",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Denise Lee",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Denise Lee",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.81887,
                        "lon": 145.12545
                    }
                },
                {
                    "facility": "Royal Brisbane and Women's Hospital",
                    "status": "RECRUITING",
                    "city": "Brisbane",
                    "zip": "QLD 4006",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Nicholas Weber",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Nicholas Weber",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.46794,
                        "lon": 153.02809
                    }
                },
                {
                    "facility": "Royal Darwin Hospital",
                    "status": "RECRUITING",
                    "city": "Darwin",
                    "zip": "NT 0810",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Emma Palfreyman",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Emma Palfreyman",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -12.46113,
                        "lon": 130.84185
                    }
                },
                {
                    "facility": "Sunshine Hospital (Western Health)",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "zip": "VIC 3021",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Michael Gilbertson",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Michael Gilbertson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Concord Repatriation General Hospital",
                    "status": "RECRUITING",
                    "city": "Sydney",
                    "zip": "NSW 2139",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Nicole Wong Doo",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Nicole Wong Doo",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.86785,
                        "lon": 151.20732
                    }
                },
                {
                    "facility": "St George Hospital",
                    "status": "RECRUITING",
                    "city": "Sydney",
                    "zip": "NSW 2217",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Fernando Roncolato",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Fernando Roncolato",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.86785,
                        "lon": 151.20732
                    }
                },
                {
                    "facility": "AZ Delta Campus Rumbeke",
                    "status": "RECRUITING",
                    "city": "Roeselare",
                    "state": "West Flanders",
                    "zip": "Deltalaan 1, 8800",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Caressa Meert",
                            "role": "CONTACT",
                            "email": "caressa.meert@azdelta.be"
                        },
                        {
                            "name": "Caressa Meert",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.94653,
                        "lon": 3.12269
                    }
                },
                {
                    "facility": "Amsterdam UMC - location VUMC",
                    "status": "RECRUITING",
                    "city": "Amsterdam",
                    "state": "De Boelelaan 1117",
                    "zip": "1081 HV",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Sanne Tonnio",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Sanne Tonnio",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Auckland City Hospital",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "1023",
                    "country": "New Zealand",
                    "contacts": [
                        {
                            "name": "Leanne Berkahn",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Leanne Berkahn",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Hospital Del Mar",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "state": "Passeig Maritim 25-29",
                    "zip": "ES 08003",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Blanca Sanchez Gonzalez",
                            "role": "CONTACT",
                            "email": "97894@parcdesalutmar.cat"
                        },
                        {
                            "name": "Blanca Sanchez Gonzalez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Institut Catala d'Oncologia",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "ES 08908",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Sureda-Balari Anna",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Sureda-Balari Anna",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Blackpool Victoria Hospital",
                    "status": "RECRUITING",
                    "city": "Blackpool",
                    "state": "Lancashire",
                    "zip": "FY3 8NR",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Mac Macheta",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Mac Macheta",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.81667,
                        "lon": -3.05
                    }
                },
                {
                    "facility": "Freeman Hospital, Newcastle",
                    "status": "RECRUITING",
                    "city": "Newcastle Upon Tyne",
                    "state": "Newcastle",
                    "zip": "NE7 7DN",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Wendy Osborne",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Wendy Osborne",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 54.97328,
                        "lon": -1.61396
                    }
                },
                {
                    "facility": "Lanarkshire",
                    "status": "RECRUITING",
                    "city": "Glasgow",
                    "state": "Scotland",
                    "zip": "G71 8BB",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Charlotte Thomas",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Charlotte Thomas",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 55.86515,
                        "lon": -4.25763
                    }
                },
                {
                    "facility": "St George's Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "Tooting",
                    "zip": "SW17 0QT",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Ruth Pettengell",
                            "role": "CONTACT"
                        },
                        {
                            "role": "CONTACT",
                            "email": "ruth.pettengell2@stgeorges.nhs.uk"
                        },
                        {
                            "name": "Ruth Pettengell",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Aberdeen Royal Infirmary",
                    "status": "RECRUITING",
                    "city": "Aberdeen",
                    "zip": "AB25 2ZN",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Dominic Culligan",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Dominic Culligan",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 57.14369,
                        "lon": -2.09814
                    }
                },
                {
                    "facility": "Glan Clwyd Hospital",
                    "status": "RECRUITING",
                    "city": "Bodelwyddan",
                    "zip": "LL18 5UJ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Earnest Heartin",
                            "role": "CONTACT",
                            "email": "earnest.heartin@wales.nhs.uk"
                        },
                        {
                            "name": "Earnest Heartin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.26827,
                        "lon": -3.50078
                    }
                },
                {
                    "facility": "Bristol Haematology and Oncology Centre",
                    "status": "RECRUITING",
                    "city": "Bristol",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Claire Burney",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Claire Burney",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.45523,
                        "lon": -2.59665
                    }
                },
                {
                    "facility": "University Hospital of Wales, Cardiff & Vale University Local Health Board",
                    "status": "RECRUITING",
                    "city": "Cardiff",
                    "zip": "CF14 4XW",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Eve Gallop-Evans",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Eve Gallop-Evans",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.48,
                        "lon": -3.18
                    }
                },
                {
                    "facility": "Beatson West of Scotland Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Glasgow",
                    "zip": "G12 0YN",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Pam McKay",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Pam McKay",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 55.86515,
                        "lon": -4.25763
                    }
                },
                {
                    "facility": "Castle Hill Hospital",
                    "status": "RECRUITING",
                    "city": "Hull",
                    "zip": "HU16 5JQ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Russell Patmore",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Russell Patmore",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.7446,
                        "lon": -0.33525
                    }
                },
                {
                    "facility": "University Hospitals of Leicester NHS Trust",
                    "status": "RECRUITING",
                    "city": "Leicester",
                    "zip": "LE1 5WW",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Sapna Ladani",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Sapna Ladani",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.6386,
                        "lon": -1.13169
                    }
                },
                {
                    "facility": "St Bartholomew's Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "EC1A 7BE",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Rifca Le Dieu",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Rifca Le Dieu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "University College London Hospitals NHS Foundation Trust (UCLH)",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "NW1 2BU",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Maria Marzolini",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Maria Marzolini",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Christie Hospital",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M20 4BX",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Beth Phillips",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Timothy Illidge",
                            "role": "CONTACT",
                            "email": "tim.illidge@manchester.ac.uk"
                        },
                        {
                            "name": "Timothy Illidge",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "Norfolk & Norwich University Hospital",
                    "status": "RECRUITING",
                    "city": "Norwich",
                    "zip": "NR4 7UY",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Nimish Shah",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Nimish Shah",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.62783,
                        "lon": 1.29834
                    }
                },
                {
                    "facility": "Nottingham University Hospitals NHST",
                    "status": "RECRUITING",
                    "city": "Nottingham",
                    "zip": "NG51PB",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Emily Chernucha",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Emily Chernucha",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.9536,
                        "lon": -1.15047
                    }
                },
                {
                    "facility": "Churchill Hospital",
                    "status": "RECRUITING",
                    "city": "Oxford",
                    "zip": "OX3 7LE",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Graham Collins",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Graham Collins",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.75222,
                        "lon": -1.25596
                    }
                },
                {
                    "facility": "Derriford Hospital",
                    "status": "RECRUITING",
                    "city": "Plymouth",
                    "zip": "PL6 8DH",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Patrick Medd",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Patrick Medd",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.37153,
                        "lon": -4.14305
                    }
                },
                {
                    "facility": "Sunderland Royal Hospital",
                    "status": "RECRUITING",
                    "city": "Sunderland",
                    "zip": "SR4 7TP",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Scott Marshall",
                            "role": "CONTACT",
                            "email": "scott.marshall3@nhs.net"
                        },
                        {
                            "name": "Scott Marshall",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 54.90465,
                        "lon": -1.38222
                    }
                },
                {
                    "facility": "Royal Marsden Hospital",
                    "status": "RECRUITING",
                    "city": "Sutton",
                    "zip": "SM2 5PT",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Sunil Iyengar",
                            "role": "CONTACT",
                            "email": "Sunil.Iyengar@rmh.nhs.uk"
                        },
                        {
                            "name": "Sunil Iyengar",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.35,
                        "lon": -0.2
                    }
                },
                {
                    "facility": "Torbay Hospital",
                    "status": "RECRUITING",
                    "city": "Torquay",
                    "zip": "TQ2 7AA",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Deborah Turner",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Deborah Turner",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.46198,
                        "lon": -3.5252
                    }
                },
                {
                    "facility": "Royal Cornwall Hospital",
                    "status": "RECRUITING",
                    "city": "Truro",
                    "zip": "TR1 3LJ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Bryson Pottinger",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Bryson Pottinger",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.26526,
                        "lon": -5.05436
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000006689",
                    "term": "Hodgkin Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9751",
                    "name": "Hodgkin Disease",
                    "asFound": "Hodgkin Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2817",
                    "name": "Hodgkin Lymphoma",
                    "asFound": "Hodgkin Lymphoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004317",
                    "term": "Doxorubicin"
                },
                {
                    "id": "D000001761",
                    "term": "Bleomycin"
                },
                {
                    "id": "D000003606",
                    "term": "Dacarbazine"
                },
                {
                    "id": "D000079963",
                    "term": "Brentuximab Vedotin"
                },
                {
                    "id": "D000014747",
                    "term": "Vinblastine"
                },
                {
                    "id": "D000008934",
                    "term": "Mitogens"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000903",
                    "term": "Antibiotics, Antineoplastic"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000059005",
                    "term": "Topoisomerase II Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000922",
                    "term": "Immunotoxins"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7492",
                    "name": "Doxorubicin",
                    "asFound": "Cognitive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1945",
                    "name": "Lenograstim",
                    "relevance": "LOW"
                },
                {
                    "id": "M227339",
                    "name": "Liposomal doxorubicin",
                    "relevance": "LOW"
                },
                {
                    "id": "M11900",
                    "name": "Mitogens",
                    "asFound": "Natural",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5042",
                    "name": "Bleomycin",
                    "asFound": "Hypotension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2088",
                    "name": "Brentuximab Vedotin",
                    "asFound": "Polymorphism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17492",
                    "name": "Vinblastine",
                    "asFound": "Oxygen saturation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6809",
                    "name": "Dacarbazine",
                    "asFound": "Affect",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M4241",
                    "name": "Immunotoxins",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}